[ Inside the business ]

DD stock analysis

DD · Dupont De Nemours, Inc.

Plastic materials, synth resins and nonvulcan elastomers. Growing 4%.

Nothing unusual in its latest filings.

The future, in 7 questions

01 What's priced in?Not available

Needs today's sales, share count and price.

02 Is the wave rising?No Radar technology matched

Not among the companies mentioning Radar's technologies most.

03 Will customers keep buying?Sales +4%, steady
Equity Method Investee 1%Everyone else
Backlog $34M · under 0.1× salesPrepaid $4MSales +4%, steady
04 Is it scarce?No
PricingBacklogPrepaidSell-outTight
05 More profit per sale?Not enough data
Before running costs: 35% → 35%
06 Can it fund itself?Pays its own way
05 yrsself-funded
Shares −3.5%/yrDebt $0
07 What could break it?2 to watch
  • Insiders sold $14M outside pre-set plans
  • Moves strongly with the S&P 500

From SEC filings, price and Radar. Not advice.

The record

Early signals

Growth speeding up.

Sales growth +4%, +4%, then +4% vs. a year ago.

What could go wrong

Few warning signs.

It has moved 1.3× the market. In the 2008 crisis it fell 83% while the market fell 51%. Debt is covered by cash.

Speculative check

Self-funding.

Passes every condition: profitable, cash-generating and financially sound.

What they sell

53% Diversified Industrials Segment.

Diversified Industrials Segment 53% · Healthcare And Water Technologies Segment 47%

Where each dollar goes

Not available.

Cost lines aren't reported in a comparable form.

Its market

1.1× the economy.

The government expects its industry, chemical manufacturing, to grow 2.2% a year to 2035, vs. 2.0% for the whole economy.

Market size and share

Your call.

There's no official size for its market. Enter one you trust to see its share, and slide to see what a bigger share would mean.

Life cycle

Shake-out.

Its cash flows are mixed, typical of a company in transition.

Earnings quality

Clean.

Its numbers don't resemble those of past manipulators. Cash covers 375¢ of each $1 of profit.

Competitive advantage

Not measurable.

Returns on capital can't be computed from its filings (common for banks and insurers).

Future bets

2% on research.

$169M a year on R&D. $336M on equipment and buildings.

All figures from Dupont De Nemours, Inc.'s SEC filings (EDGAR) unless tagged otherwise. Educational only, not investment advice.